000			03026nam a22002657a 4500
001			R000755
003			PILC
005			20240807132213.0
008			240807b |||||||| |||| 00| 0 eng d
040			_beng _cFEU-NRMF MEDICAL LIBRARY _drda
041			_aeng
050			_aMED 2023 0005
245			_aFactors affecting the outcome of covid 19 patients with hypertension admitted in FEU-NRMF medical center from JANUARY to DECEMBER, 2021. / _b[investigator]: Calda, Daniele Alek L.
260			_aFairview, Quezon City: _bDepartment of Medicine, FEU-NRMF, _c2023
300			_c(in folder) _ewith flash drive (soft copy)
336			_2rdacontent _atext
337			_2rdamedia _aunmediated
338			_2rdacarrier _avolume
504			_aIncludes bibliographical references.
520			_aABSTRACT: Introduction: The world has suffered from the outbreak of a pandemic caused by the severe acute respiratory syndrome coronavirus SARS-CoV-2 that causes the disease called COVID-19, first reported in Wuhan, Hubei Province, China on 31 December 2019. Interestingly, specific comorbidities associated with increased risk of infection and worse outcomes with development of increased severity of lung injury and mortality have been reported. The most common comorbidities were hypertension (30%), diabetes (19%), and coronary heart disease (8%) General Objective: To describe the outcome of COVID-19 confirmed patients with hypertension, admitted in FEU-NRMF Medical Center from January-December 2021 Methodology: Retrospective research design was used in this study. The principal investigator ensured the completeness of each medical records. An incomplete data needed for the analysis were subjected for exclusion. Data were collected via a chart review by obtaining consent Demographic profiles (age, sex, comorbidities), and clinical outcomes (number of hospital days, disposition, mortality) were obtained via chart review. Results: The majority of hypertensive patients were > 60 years old (96; 61,8%), female (81;51.6%), were overweight (66; 42%). Aside from hypertension, DM was also noted as co-morbidity (57; 36.3%). Most these patients were unvaccinated (127; 80.9%). The largest group had uncontrolled hypertension (87; 55.3%) and had hypertension for 0-5 years (54; 34.8%). COVID 19 with hypertension had an increased risk for ICU admission (OR 1.69 [95% Cl 1.3-2.2], p .000 < .05). Hypertensive patients were noted to account for the highest number of extended hospitals stay (14-21 days; 28 (17,8%) and > 21 days; 12 (7.6%), intubation (46; 29.3%), and mortality (30; 19.1%). Conclusions: Hypertension as a comorbidity, especially with no history of COVID 19 vaccination, may potentially compromise the outcome of patients. This was based on the fact that hypertensive COVID 19 patients were seen to have higher likelihood of ICU admission. Keywords: COVID 19, Hypertension, Outcome
521			_arefooah _aRESDM
700			_aCalda, Daniele Alek L. _einvestigator
856			_21
942			_2lcc _cRE
999			_c13001 _d13001